Previous | 
Home
Section: Bilateral Contracts and Grants with Industry
Bilateral Contracts with Industry
Research contract between the pharmaceutical company Roche and the MONC team.
Overall Objectives
Research Program
Application Domains
New Software and Platforms
New Results
- Mathematical Modeling of the Proliferation Gradient in MultiCellular Tumor Spheroids
- Viscoelastic modeling of the fusion of multicellular tumor spheroids in growth phase
- Mathematical analysis and 2-scale convergence of a heterogeneous microscopic bidomain model
- Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy
- T2‐based MRI Delta‐radiomics improve response prediction in soft‐tissue sarcomas treated by neoadjuvant chemotherapy
- Revisiting bevacizumab + cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non-small cell lung carcinoma
Bilateral Contracts and Grants with Industry
Partnerships and Cooperations
Bibliography
Overall Objectives
Research Program
Application Domains
New Software and Platforms
New Results
- Mathematical Modeling of the Proliferation Gradient in MultiCellular Tumor Spheroids
- Viscoelastic modeling of the fusion of multicellular tumor spheroids in growth phase
- Mathematical analysis and 2-scale convergence of a heterogeneous microscopic bidomain model
- Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy
- T2‐based MRI Delta‐radiomics improve response prediction in soft‐tissue sarcomas treated by neoadjuvant chemotherapy
- Revisiting bevacizumab + cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non-small cell lung carcinoma
Bilateral Contracts and Grants with Industry
Partnerships and Cooperations
Bibliography